VCI Global to Develop Next-Generation AI Computing Data Center for the Next Industrial Revolution

New Report From Meltwater and Asana Reveals Disconnect Between Marketing Goals and Business Objectives

Descartes’ Study Shows 40% of Shippers and Logistics Services Providers Plan to Invest in Transportation Technology to Address Industry Changes

Bedford Metals Engages CanExplor Management for Satellite Survey of Ubiquity Lake Uranium Project

Infocom Receives Prestigious Honor at 2024 Asia-Pacific Stevie Awards

President Lula to Speak at FII PRIORITY Rio de Janeiro Summit at the Copacabana Palace Wednesday

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

Notified -

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

LambdaTest Introduces Smart UI Figma CLI to Streamline Visual Regression Testing for Design Teams

Sea Index CO2 certification for superyachts earns Capenergies Label

PAP Therapy Reduces Hospitalizations by 31% and ER Visits by 23% for People with Obstructive Sleep Apnea and Comorbid Insomnia

Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer